View Single Post
Old 12-10-2015, 06:30 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 20,148
SABCS15: Promising phase 1 results lead to phase 2 for ONT-380 in HER2+ breast cancer

Results of an ongoing phase 1b clinical trial presented at the 2015 San Antonio Breast Cancer Symposium show promise of the experimental anti-cancer agent ONT-380 against metastatic HER2+ breast...

More...
News is offline   Reply With Quote